RESUMO
BACKGROUND: Previous studies have shown that a calcium (Ca) pre-rinse given before a 228 ppm fluoride (F) rinse greatly increased salivary fluoride. Objectives. The aim of this randomized controlled trial is to examine if Ca pre-rinse could increase the fluoride concentration in the overnight unstimulated saliva after a 905 ppm F-rinse. MATERIALS AND METHODS: Pre-rinses containing 150 mM, 75 mM or 0 mM Ca-lactate prepared by a validated pharmaceutical cGPM procedure were tested by nine subjects in a randomized order immediately followed by a 905 ppm F-rinse. The fluoride concentration was measured in unstimulated saliva collected 10 h later. RESULTS AND CONCLUSIONS: The Ca pre-treatment significantly increased F level in overnight saliva following the 905 ppm fluoride rinse by 1.7× relative to the 905 ppm F-rinse alone; however, a significant effect was only observed with the highest (150 mM) Ca concentration as pre-rinse. Clinical relevance. High concentration F rinses (905 ppm) are commonly recommended for patients at high-risk of caries. A pre-treatment with high levels of Ca may further improve the cariostatic effect of this ion.
Assuntos
Compostos de Cálcio/uso terapêutico , Cariostáticos/uso terapêutico , Lactatos/uso terapêutico , Antissépticos Bucais/uso terapêutico , Saliva/química , Fluoreto de Sódio/uso terapêutico , Adulto , Compostos de Cálcio/administração & dosagem , Compostos de Cálcio/análise , Cariostáticos/administração & dosagem , Cariostáticos/análise , Estudos Cross-Over , Método Duplo-Cego , Feminino , Humanos , Lactatos/administração & dosagem , Lactatos/análise , Masculino , Pessoa de Meia-Idade , Antissépticos Bucais/administração & dosagem , Cooperação do Paciente , Satisfação do Paciente , Saliva/metabolismo , Taxa Secretória/fisiologia , Fluoreto de Sódio/administração & dosagem , Fluoreto de Sódio/análise , Resultado do TratamentoRESUMO
Current models for increasing the anti-caries effects of fluoride (F) agents emphasize the importance of maintaining a cariostatic concentration of F in oral fluids. The concentration of F in oral fluids is maintained by the release of this ion from bioavailable reservoirs on the teeth, oral mucosa and - most importantly, because of its association with the caries process - dental plaque. Oral F reservoirs appear to be of two types: (1) mineral reservoirs, in particular calcium fluoride or phosphate-contaminated 'calcium-fluoride-like' deposits; (2) biological reservoirs, in particular (with regard to dental plaque) F held to bacteria or bacterial fragments via calcium-fluoride bonds. The fact that all these reservoirs are mediated by calcium implies that their formation is limited by the low concentration of calcium in oral fluids. By using novel procedures which overcome this limitation, the formation of these F reservoirs after topical F application can be greatly increased. Although these increases are associated with substantive increases in salivary and plaque fluid F, and hence a potential increase in cariostatic effect, it is unclear if such changes are related to the increases in the amount of these reservoirs, or changes in the types of F deposits formed. New techniques have been developed for identifying and quantifying these deposits which should prove useful in developing agents that enhance formation of oral F reservoirs with optimum F release characteristics. Such research offers the prospect of decreasing the F content of topical agents while simultaneously increasing their cariostatic effect.